Valuation: EMV Capital plc

Market Cap 14.96M 19.91M 17.5M 16.29M 28.1M 1.91B 28.47M 194M 75.64M 943M 74.74M 73.13M 3.26B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 13.93M 18.54M 16.3M 15.17M 26.16M 1.78B 26.51M 180M 70.44M 878M 69.6M 68.1M 3.03B EV / Sales 2026 *
4.06x
EV / Sales 2027 * 4.05x
Free-Float
52.46%
Yield 2026 *
-
Yield 2027 * -
1 week+0.94%
Current month+3.88%
1 month+3.88%
3 months+16.30%
6 months-4.46%
Current year-6.14%
1 week 52
Extreme 52
55
1 month 51
Extreme 51
55
Current year 44
Extreme 44
62
1 year 40
Extreme 40
62
3 years 34
Extreme 34
80.5
5 years 34
Extreme 34
137
10 years 9.75
Extreme 9.75
846
Manager TitleAgeSince
Chief Executive Officer 50 01/05/2020
Director of Finance/CFO 45 01/12/2025
Chief Investment Officer - -
Director TitleAgeSince
Director/Board Member 50 14/10/2019
Director/Board Member 47 09/12/2022
Chairman 61 01/02/2023
Date Insider Type Main position Quantity % Market Cap.
08/01/26 Sell 7,000 0.0250%
08/01/26 Buy 7,000 0.0250%
19/12/25 Sell

Director

34,484 0.1242%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.94%-5.31%-13.71% 19.91M
-0.77%+3.19%+62.13%+16.27% 3.51B
+0.38%-1.68%-18.78%-3.43% 2.91B
+0.99%+4.07%+54.03%+26.11% 2.05B
-2.76%+3.60%+80.66%+126.74% 1.29B
0.00%0.00%-1.72%-7.02% 717M
+0.82%+1.35%+103.93%+186.02% 488M
-2.10%-2.10%-6.67%-10.26% 397M
0.00%0.00%-44.44%-75.18% 384M
0.00%0.00%-2.71%-12.24% 373M
Average -0.31%+1.10%+22.11%+23.33% 1.21B
Weighted average by Cap. -0.23%+1.48%+33.53%+25.74%

Financials

2026 *2027 *
Net sales 3.43M 4.56M 4.01M 3.73M 6.44M 438M 6.52M 44.39M 17.34M 216M 17.13M 16.76M 747M 3.75M 4.99M 4.39M 4.09M 7.05M 479M 7.14M 48.57M 18.97M 236M 18.74M 18.34M 817M
Net income - -
Net Debt -1.03M -1.37M -1.2M -1.12M -1.93M -131M -1.96M -13.32M -5.2M -64.83M -5.14M -5.03M -224M 233K 310K 272K 253K 437K 29.7M 443K 3.01M 1.18M 14.67M 1.16M 1.14M 50.7M
Logo EMV Capital plc
EMV Capital plc is a United Kingdom-based deep tech and life sciences venture capital (VC) investment group with an international portfolio of companies. The Company identifies, invests in, and builds high-growth companies in the United Kingdom and internationally. It employs a capital-light investment approach, making use of its balance sheet and syndicating investments through its wholly owned VC subsidiary, EMV Capital Partners Limited. It secures a mixture of direct equity stakes and carried interest stakes in its portfolio of companies, creating a structure that can support a large portfolio. The Company has a portfolio of approximately 70 companies with a focus on life sciences, industrials, robotics & artificial intelligence (AI), and sustainability. Its subsidiaries include Glycotest, Inc., CetroMed Limited, NetScientific America, Inc., EMV Director Services Limited, EMV Capital Technology Limited, and ProAxsis Limited, among others.
Employees
21
Date Price Change Volume
28/07/26 GBX 53.50 0.00% 0
27/07/26 GBX 53.50 0.00% 9,915
24/07/26 GBX 53.50 +0.94% 7,317
23/07/26 GBX 53.00 0.00% 57,971
22/07/26 GBX 53.00 0.00% 214
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.5350GBP
Average target price
1.320GBP
Spread / Average Target
+146.73%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EMVC Stock